Companies

AbbVie

AbbVie develops therapies in immunology, oncology, neuroscience, and eye care, building on the legacy of Humira with next-generation biologics. Its research collaborations with universities advance antibody-drug conjugates and targeted protein degradation.

Details

Industry

Biopharma

R&D Spend

$8.0B